ProKidney Stock (NASDAQ: PROK) stock price, news, charts, stock research, profile.
You can purchase shares of ProKidney (NASDAQ:PROK) through any online brokerage.
Other companies in ProKidney’s space includes: Zentalis Pharma (NASDAQ:ZNTL), Fate Therapeutics (NASDAQ:FATE), Anika Therapeutics (NASDAQ:ANIK), Eledon Pharma (NASDAQ:ELDN) and aTyr Pharma (NASDAQ:ATYR).
ProKidney has a consensus price target of $10.13.
The stock price for ProKidney (NASDAQ: PROK) is $1.71 last updated November 22, 2024 at 7:24 PM EST.
There are no upcoming dividends for ProKidney.
ProKidney’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for ProKidney.
ProKidney is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.